PTSD | MAPS Public Benefit Corporation

Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Psychotherapy for PTSD

May 10, 2019 | Press Releases

Today, the overall results of six Phase 2 clinical trials of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) were published in the peer-reviewed journal Psychopharmacology. The paper is the most comprehensive analysis yet...

MAPS Public Benefit Corporation

Our Mission
Who We Are
Careers
News
Contact Us
Privacy Policy
Cookie Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

Our Research

Investigator-Initiated Trials and Studies
Participate in Trials

Therapy Education for Healthcare Providers

Our Commitment to Therapy Education

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Sitemap